MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsyRyo Ogawa, Kazuo Fujihara, Ichiro Nakashima et al.|Neurology Neuroimmunology & Neuroinflammation|2017Cited by 432
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implicationsKimihiko Kaneko, Masashi Aoki, Shuhei Nishiyama et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 199
Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum DisorderTetsuya Akaishi, Ichiro Nakashima, Toshiyuki Takahashi et al.|Neurology|2021Cited by 90
Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disordersTetsuya Akaishi, Ichiro Nakashima, Toshiyuki Takahashi et al.|Journal of Neurology|2021Cited by 44
Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapyYoshiki Takai, Masashi Aoki, Hiroshi Kuroda et al.|Multiple Sclerosis and Related Disorders|2021Cited by 43